|
GB201919155D0
|
|
Predictive markers of psychosis
|
|
GB201917246D0
|
|
A collagen scaffold
|
|
GB201821014D0
|
|
Star polypeptides
|
|
CN111615380A
|
|
Thermally responsive hydrogels for intratumoral administration as a treatment of solid tumor cancer
|
|
GB201813810D0
|
|
Polyethylene glycol (peg)-based peptidomimetics
|
|
GB201808285D0
|
|
Labelling of extracellular vesicles
|
|
EP3568857A1
|
|
A method for monitoring adherence to medication
|
|
GB201717590D0
|
|
Particles
|
|
WO2018015493A1
|
|
Metal complexes having therapeutic applications
|
|
EP3207937A1
|
|
A method of treating or preventing sepsis
|
|
EP2493898A1
|
|
Fluorescent near infra-red (nir) dyes
|
|
EP2454267A2
|
|
Metal complexes having dual histone deacetylase inhibitory and dna-binding activity
|
|
CA2750605A1
|
|
Layered scaffold suitable for osteochondral repair
|
|
US2011257139A1
|
|
Treatment of diarrhoea
|
|
EP2332607A1
|
|
A urethral catheter
|
|
WO2010007604A2
|
|
Inhalable microparticles, and methods for the production thereof
|
|
AU2006211092A1
|
|
Pharmacogenomics of blood pressure lowering agents
|
